Literature DB >> 26646243

The Role of Neuropeptides in Mouse Models of Colitis.

David Padua1, John P Vu1,2, Patrizia M Germano2, Joseph R Pisegna3,4.   

Abstract

Inflammatory bowel disease (IBD) constitutes an important clinically significant condition that results in morbidity and mortality. IBD can be generally classified into either ulcerative colitis (UC) or Crohn's disease (CD) that differs in the clinical and histopathology. The role of neuropeptides in the pathogenesis of these conditions is becoming increasingly recognized for their importance in modulating the inflammatory state. Animal models provide the greatest insight to better understand the pathophysiology of both disorders which will hopefully allow for improved treatment strategies. This review will provide a better understanding of the role of murine models for studying colitis.

Entities:  

Keywords:  Gastric acid secretion; Gastrin; Gastrointestinal hormones; Pituitary adenylate cyclase-activating polypeptide (PACAP); Vasoactive intestinal polypeptide (VIP)

Mesh:

Substances:

Year:  2015        PMID: 26646243      PMCID: PMC4884658          DOI: 10.1007/s12031-015-0688-1

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  74 in total

1.  The production of an experimental ulcerative colitis in rabbits.

Authors:  J B KIRSNER; J ELCHLEPP
Journal:  Trans Assoc Am Physicians       Date:  1957

2.  Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn's Disease.

Authors:  Giovanni Monteleone; Francesco Pallone
Journal:  N Engl J Med       Date:  2015-06-18       Impact factor: 91.245

3.  T cell-induced inflammation of the small and large intestine in immunodeficient mice.

Authors:  Dmitry V Ostanin; Kevin P Pavlick; Sulaiman Bharwani; Dwain D'Souza; Kathryn L Furr; Carla M Brown; Matthew B Grisham
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-08-11       Impact factor: 4.052

Review 4.  Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation.

Authors:  Ana Izcue; Janine L Coombes; Fiona Powrie
Journal:  Immunol Rev       Date:  2006-08       Impact factor: 12.988

5.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

6.  Structure, functional expression, and cerebral localization of the levocabastine-sensitive neurotensin/neuromedin N receptor from mouse brain.

Authors:  J Mazella; J M Botto; E Guillemare; T Coppola; P Sarret; J P Vincent
Journal:  J Neurosci       Date:  1996-09-15       Impact factor: 6.167

7.  Vasoactive intestinal peptide-deficient mice exhibit reduced pathology in trinitrobenzene sulfonic acid-induced colitis.

Authors:  Catalina Abad; Gardenia Cheung-Lau; Anne-Claire Coûté-Monvoisin; James A Waschek
Journal:  Neuroimmunomodulation       Date:  2014-10-03       Impact factor: 2.492

8.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.

Authors:  D F Fiorentino; M W Bond; T R Mosmann
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

9.  Vasoactive intestinal polypeptide promotes intestinal barrier homeostasis and protection against colitis in mice.

Authors:  Xiujuan Wu; Victoria S Conlin; Vijay Morampudi; Natasha R Ryz; Yasmin Nasser; Ganive Bhinder; Kirk S Bergstrom; Hong B Yu; Chris C M Waterhouse; Allison M J Buchan; Oana E Popescu; William T Gibson; James A Waschek; Bruce A Vallance; Kevan Jacobson
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

Review 10.  Next-Generation Therapeutics for IBD.

Authors:  Mark Löwenberg; Geert D'Haens
Journal:  Curr Gastroenterol Rep       Date:  2015-06
View more
  15 in total

1.  Focal, but not global, cerebral ischaemia causes loss of myenteric neurons and upregulation of vasoactive intestinal peptide in mouse ileum.

Authors:  Xiaowen Cheng; Martina Svensson; Yiyi Yang; Tomas Deierborg; Eva Ekblad; Ulrikke Voss
Journal:  Int J Exp Pathol       Date:  2018-03-25       Impact factor: 1.925

2.  Early Neurobehavioral Development of Mice Lacking Endogenous PACAP.

Authors:  Jozsef Farkas; Balazs Sandor; Andrea Tamas; Peter Kiss; Hitoshi Hashimoto; Andras D Nagy; Balazs D Fulop; Tamas Juhasz; Sridharan Manavalan; Dora Reglodi
Journal:  J Mol Neurosci       Date:  2017-02-06       Impact factor: 3.444

3.  The Protective Role of PAC1-Receptor Agonist Maxadilan in BCCAO-Induced Retinal Degeneration.

Authors:  A Vaczy; D Reglodi; T Somoskeoy; K Kovacs; E Lokos; E Szabo; A Tamas; T Atlasz
Journal:  J Mol Neurosci       Date:  2016-08-26       Impact factor: 3.444

4.  Expression of PACAP and PAC1 Receptor in Normal Human Thyroid Gland and in Thyroid Papillary Carcinoma.

Authors:  Sebastian Bardosi; Attila Bardosi; Zsuzsanna Nagy; Dora Reglodi
Journal:  J Mol Neurosci       Date:  2016-08-26       Impact factor: 3.444

Review 5.  PACAP deficiency as a model of aging.

Authors:  D Reglodi; T Atlasz; E Szabo; A Jungling; A Tamas; T Juhasz; B D Fulop; A Bardosi
Journal:  Geroscience       Date:  2018-10-22       Impact factor: 7.713

Review 6.  Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease.

Authors:  Magdy El-Salhy; Tefera Solomon; Trygve Hausken; Odd Helge Gilja; Jan Gunnar Hatlebakk
Journal:  World J Gastroenterol       Date:  2017-07-28       Impact factor: 5.742

Review 7.  The Therapeutic Potential of Targeting Substance P/NK-1R Interactions in Inflammatory CNS Disorders.

Authors:  M Brittany Johnson; Ada D Young; Ian Marriott
Journal:  Front Cell Neurosci       Date:  2017-01-04       Impact factor: 5.505

Review 8.  Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system.

Authors:  Mari Iwasaki; Yasutada Akiba; Jonathan D Kaunitz
Journal:  F1000Res       Date:  2019-09-12

Review 9.  Presence and Effects of Pituitary Adenylate Cyclase Activating Polypeptide Under Physiological and Pathological Conditions in the Stomach.

Authors:  Dora Reglodi; Anita Illes; Balazs Opper; Eszter Schafer; Andrea Tamas; Gabriella Horvath
Journal:  Front Endocrinol (Lausanne)       Date:  2018-03-19       Impact factor: 5.555

10.  Temporal clinical, proteomic, histological and cellular immune responses of dextran sulfate sodium-induced acute colitis.

Authors:  Natalia Schneider Nunes; Saejeong Kim; Maggie Sundby; Parwathy Chandran; Scott Robert Burks; Ana Helena Paz; Joseph Alan Frank
Journal:  World J Gastroenterol       Date:  2018-10-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.